Abstract
The use of Personalised Interactive Music Systems (PIMS) may provide benefits in promoting physical activity levels. This systematic review and meta-analysis was conducted to assess the overall impact of PIMS in physical activity and exercise domains. Separate random effects meta-analyses were conducted for outcomes in physical activity levels, physical exertion, rate of perceived exertion (RPE), and affect. In total, 18 studies were identified. Of these, six studies (with 17 total intervention arms) reported data on at least one outcome of interest, from which an effect size could be calculated. PIMS were significantly associated with beneficial changes in physical activity levels (g = 0.49, CI [0.07, 0.91], p = 0.02, k = 4, n = 76) and affect (g = 1.68, CI [0.15, 3.20], p = 0.03, k = 4, n = 122). However, no significant benefit of PIMS use was found for RPE (g = 0.72, CI [- 0.14, 1.59], p = 0.10, k = 3, n = 77) or physical exertion (g = 0.79, CI [-0.64, 2.10], p = 0.28, k = 5, n = 142). Overall, results support the preliminary use of PIMS across a variety of physical activities to promote physical activity levels and positive affect.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The authors declared that the work was supported by the Research Council of Finland program 2022, 2029.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Author list updated. Clarified language use in Discussion. Figures 3 to 6 captions revised.
1 Eligible studies included a control group and intervention arm targeting the outcome of interest.
2 Page et al (2021). The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021;372:n71. doi: 10.1136/bmj.n71
3 McGuinness, L. A., & Higgins, J. P. T. (2021). Risk-of-bias VISualization (robvis): An R package and Shiny web app for visualizing risk-of-bias assessments. Res Syn Meth. 2020; 1-7. https://doi.org/10.1002/jrsm.1411
Data Availability
The authors confirm that the data supporting the findings of this study are available within the article [and/or] its supplementary materials accessed here: OSF, https://osf.io/jpy5k/
